Xeloda var i kombination med cisplatin non- inferiørt i forhold til 5- FU i kombination med cisplatin med hensyn til progressionsfri overlevelse i per protokolanalysen (hazard ratio 0, 81; 95% konfidensinterval 0, 63 – 1, 04).
Xeloda in combination with cisplatin was non-inferior to 5-FU in combination with cisplatin in terms of progression-free survival in the per protocol analysis (hazard ratio 0.81; 95% CI 0.63 - 1.04).